Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fraction-Reference-Cited by-同舟云学术

Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fraction

Published:1996-06 Issue:16 Volume:77 Page:16D-21D
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Hansen J. Fischer,Tingsted Lisbeth,Rasmussen Verner,Madsen Johnny K.,Jespersen Christian M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference42 articles.

1. Clinical use of calcium antagonist drugs;Opie,1990

2. Myocardial protection by calcium antagonists;Opie,1994

3. Pathophysiological mechanisms underlying the adverse effect of calcium channel-blocking drugs in patients with chronic heart failure;Packer;Circulation,1989

4. The effect of verapamil on mortality and major events after myocardial infarction. The Danish Verapamil Infarction Trial (DAVIT) II;Am J Cardiol,1990

5. Secondary prevention with verapamil after myocardial infarction;Am J Cardiol,1990

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systolic blood pressure, heart rate, and outcomes in patients with coronary disease and heart failure;ESC Heart Failure;2019-12-15

2. Treatment of Hypertension in Patients With Coronary Artery Disease;Hypertension;2015-06

3. Treatment of hypertension in patients with coronary artery disease;Journal of the American Society of Hypertension;2015-06

4. Treatment of Hypertension in Patients With Coronary Artery Disease;Circulation;2015-05-12

5. Treatment of Hypertension in Patients With Coronary Artery Disease;Journal of the American College of Cardiology;2015-05